Memorial Sloan Kettering Radiation Oncology shared on X:
“New in Cancer Discovery from The Pike Laboratory:
Changes in genome-wide cell-free DNA reflected genomic and chromatin characteristics of lung cancer. A machine learning model identify individuals who were more or less likely to have LCSM and could save lives.”
Clinical validation of a cell-free DNA fragmentome assay for augmentation of lung cancer early detection published in Cancer Discovery
Autors: Peter J. Mazzone, Peter B. Bach, Jacob CareyCaitlin A. SchonewolfKatalin Bognar, Manmeet S. Ahluwalia, Marcia Cruz-CorreaDavid GieradaSonali Kotagiri, Kathryn Lloyd, Fabien Maldonado, Jesse D. Ortendahl, Lecia V. Sequist, Gerard A. Silvestri, Nichole Tanner, Jeffrey C. ThompsonAnil Vachani, Kwok-Kin Wong, Ali H. Zaidi, Joseph Catallini, Ariel Gershman, Keith LumbardLaurel K. MillbergJeff NawrockiCarter PortwoodAakanksha RangnekarCarolina Campos. Sheridan, Niti TrivediTony WuYuhua ZongLindsey CottonAllison RyanChristopher CisarAlessandro LealNicholas C. DracopoliRobert B. ScharpfVictor E. VelculescuLuke R. G. Pike.
